Actor, Hodgkin's Survivor, To Star in New Show

US actor Brian Watson, best known for his role as Matt Camden in the television series "7th Heaven" returns to television in the title role of the new ABC series "What About Brian" this Sunday.



He was diagnosed with Hodgkin's lymphoma in May 2002, and went on hiatus acting in 7th Heaven while he sought treatment. While undergoing chemotherapy, he changed gears and joined the show's writing staff. "He's been inspirational" said 7th Heaven producer Brenda Hampton in a TV Guide interview at the time. He reportedly reached remission in April 2003, and he began appearing on the program again, starting with the 150th episode. He returned as a recurring cast member.



In What About Brian, Watson stars as Brian, a well-meaning guy who runs a video business called Zap Monkey. Brian is one of those guys who is loved by everyone except the girl he loves, Marjorie (Sarah Lancaster), who also is his best friend's girlfriend.



We're glad Watson has had a lasting remission and wish him the best in the new series.

Blog Category: 

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap